Guneesh S Uberoi1, Angad S Uberoi1, Manoop S Bhutani2. 1. Department of Gastroenterology, Hepatology and Nutrition-Unit 1466, UT MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030-4009, USA. 2. Department of Gastroenterology, Hepatology and Nutrition-Unit 1466, UT MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030-4009, USA. manoop.bhutani@mdanderson.org.
Abstract
PURPOSE OF REVIEW: Locally advanced esophageal cancer is frequently treated preoperatively with chemotherapy and radiation. The degree of response to this preoperative therapy varies in different patients, and a complete pathological response (pCR) has important implications in the management and prognosis of these patients. This is a review of the different modalities currently available to detect pCR and the clinical context of their use. RECENT FINDINGS: While research is still ongoing, no single technique has emerged as the modality of choice to reliably predict pCR in all patients. Studies investigating the sensitivity, specificity, and accuracy of these modalities have had promising results, but no single modality has been firmly validated as the modality if choice. The emergence of functional imaging techniques and the use of biomarkers are newer developments which need further evaluation before adoption in routine clinical practice. While no single technique reliably predicts pCR, a combination of imaging and diagnostic modalities (endoscopic appearance, biopsy, EUS, and PET/CT) may provide a better diagnostic yield rather than any of these modalities taken alone.
PURPOSE OF REVIEW: Locally advanced esophageal cancer is frequently treated preoperatively with chemotherapy and radiation. The degree of response to this preoperative therapy varies in different patients, and a complete pathological response (pCR) has important implications in the management and prognosis of these patients. This is a review of the different modalities currently available to detect pCR and the clinical context of their use. RECENT FINDINGS: While research is still ongoing, no single technique has emerged as the modality of choice to reliably predict pCR in all patients. Studies investigating the sensitivity, specificity, and accuracy of these modalities have had promising results, but no single modality has been firmly validated as the modality if choice. The emergence of functional imaging techniques and the use of biomarkers are newer developments which need further evaluation before adoption in routine clinical practice. While no single technique reliably predicts pCR, a combination of imaging and diagnostic modalities (endoscopic appearance, biopsy, EUS, and PET/CT) may provide a better diagnostic yield rather than any of these modalities taken alone.
Authors: Peter S N van Rossum; Astrid L H M W van Lier; Marco van Vulpen; Onne Reerink; Jan J W Lagendijk; Steven H Lin; Richard van Hillegersberg; Jelle P Ruurda; Gert J Meijer; Irene M Lips Journal: Radiother Oncol Date: 2015-05-19 Impact factor: 6.280
Authors: Christian Jost; Janek Binek; Jan C Schuller; Peter Bauerfeind; Urs Metzger; Baseli Werth; Juerg Knuchel; Jean-Louis Frossard; Philipp Bertschinger; Peter Brauchli; Christa Meyenberger; Thomas Ruhstaller Journal: Gastrointest Endosc Date: 2010-03-20 Impact factor: 9.427
Authors: J A Ajani; X Wang; S Song; A Suzuki; T Taketa; K Sudo; R Wadhwa; W L Hofstetter; R Komaki; D M Maru; J H Lee; M S Bhutani; B Weston; V Baladandayuthapani; Y Yao; S Honjo; A W Scott; H D Skinner; R L Johnson; D Berry Journal: Mol Oncol Date: 2013-10-28 Impact factor: 6.603
Authors: Paul M Schneider; Ralf Metzger; Hartmut Schaefer; Frank Baumgarten; Daniel Vallbohmer; Jan Brabender; Eva Wolfgarten; Elfriede Bollschweiler; Stephan E Baldus; Hans P Dienes; Arnulf H Hoelscher Journal: Ann Surg Date: 2008-12 Impact factor: 12.969
Authors: Peter S N van Rossum; David V Fried; Lifei Zhang; Wayne L Hofstetter; Marco van Vulpen; Gert J Meijer; Laurence E Court; Steven H Lin Journal: J Nucl Med Date: 2016-01-21 Impact factor: 10.057
Authors: Peter S N van Rossum; Lucas Goense; Jihane Meziani; Johannes B Reitsma; Peter D Siersema; Frank P Vleggaar; Marco van Vulpen; Gert J Meijer; Jelle P Ruurda; Richard van Hillegersberg Journal: Gastrointest Endosc Date: 2015-11-26 Impact factor: 9.427
Authors: Puja G Khaitan; Tyler Holliday; Austin Carroll; Wayne L Hofstetter; Erin M Bayley; Nicolas Zhou; Sameer Desale; Thomas J Watson Journal: J Gastrointest Surg Date: 2022-04-12 Impact factor: 3.267